Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Vibegron: Precautions During Medication Use1.Preparation Before the VisitPatients are advised to keep a voiding diary for at least 2–3 consecutive days before seeing the doctor.The···【more】
Article source：Captain MedicineRelease date：2026-08-07Recommended：281
How to Take Vibegron Correctly1. Standard Dosage and AdministrationThe recommended adult dose is 75 mg once daily, taken at a fixed time in the morning or evening, with or without ···【more】
Article source：Captain MedicineRelease date：2026-08-07Recommended：388
How effective is Vibegron?1. Significant improvement in three core symptoms (12-week data)In a 12-week randomized double-blind placebo-controlled trial, the Vibegron treatment grou···【more】
Article source：Captain MedicineRelease date：2026-08-06Recommended：363
Serious Risks of IbrutinibAlthough rare, ibrutinib may cause life-threatening adverse events. You need to be familiar with the following "red flags":Bleeding: Black stool···【more】
Article source：Captain MedicineRelease date：2026-08-05Recommended：474
Storage Conditions and Drug Stability for IbrutinibProper storage ensures the efficacy and safety of ibrutinib. Follow these specific guidelines:Capsules and tablets: Store at room···【more】
Article source：Captain MedicineRelease date：2026-08-04Recommended：338
Common Side Effects of IbrutinibSimilar to other anticancer agents, ibrutinib treatment may cause a number of common adverse reactions, mostly mild to moderate in severity, but req···【more】
Article source：Captain MedicineRelease date：2026-08-03Recommended：436
Key Personal Information to Tell Your Doctor Before Starting Alectinib (Alecensa)Before initiating treatment with alectinib, patients must fully disclose their health status to the···【more】
Article source：Captain MedicineRelease date：2026-07-31Recommended：324
Common Side Effects of Alectinib and Daily Management RecommendationsAlthough alectinib is highly targeted, it may still cause some common, generally reversible adverse reactions. ···【more】
Article source：Captain MedicineRelease date：2026-07-30Recommended：328
Common Side Effects of Quizartinib and Management Strategies(1) Common side effects of quizartinib involve multiple systems, with higher incidences including: leukopenia (which may···【more】
Article source：Captain MedicineRelease date：2026-07-29Recommended：287
What is Quizartinib?(1) Quizartinib (generic name: quizartinib) is a prescription targeted therapy specifically indicated for the treatment of adult patients with acute myeloid leu···【more】
Article source：Captain MedicineRelease date：2026-07-28Recommended：413
Dacomitinib - Early Identification of Interstitial Lung Disease (ILD)Although the incidence of ILD is low, its potentially fatal nature requires a "zero-tolerance" monito···【more】
Article source：Captain MedicineRelease date：2026-07-24Recommended：339
Dacomitinib Dermatologic Adverse Reactions and Management StrategiesRash and exfoliative skin reactions are highly characteristic adverse reactions of dacomitinib, and their incide···【more】
Article source：Captain MedicineRelease date：2026-07-22Recommended：305
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8542025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10512024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3192026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4082026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：6032026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5822026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4622026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6142026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
